Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Genmab A (GMAB) Gross Profit (2024 - 2025)

Historic Gross Profit for Genmab A (GMAB) over the last 2 years, with Q4 2025 value amounting to $1.2 billion.

  • Genmab A's Gross Profit rose 3885.71% to $1.2 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $3.7 billion, marking a year-over-year increase of 2491.6%. This contributed to the annual value of $3.7 billion for FY2025, which is 2491.6% up from last year.
  • As of Q4 2025, Genmab A's Gross Profit stood at $1.2 billion, which was up 3885.71% from $964.0 million recorded in Q3 2025.
  • In the past 5 years, Genmab A's Gross Profit registered a high of $1.2 billion during Q4 2025, and its lowest value of $576.0 million during Q1 2024.